Skip to content
2000
Volume 13, Issue 2
  • ISSN: 1872-3128
  • E-ISSN: 1874-0758

Abstract

Advanced medical services and treatments are available for treating Tuberculosis. Related prevalence has increased in recent times. Unfortunately, the continuous consumption of related drugs is also known for inducing hepatotoxicity which is a critical condition and cannot be overlooked. The present review article has focused on the pathways causing these toxicities and also the role of enzyme CYP2E1, hepatic glutathione, Nrf2-ARE signaling pathway, and Membrane Permeability Transition as possible targets which may help in preventing the hepatotoxicity induced by the drugs used in the treatment of tuberculosis.

Loading

Article metrics loading...

/content/journals/dml/10.2174/1872312813666190716155930
2019-12-01
2025-09-24
Loading full text...

Full text loading...

/content/journals/dml/10.2174/1872312813666190716155930
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test